Royal Bank Of Canada Lyra Therapeutics, Inc. Transaction History
Royal Bank Of Canada
- $479 Billion
- Q4 2024
A detailed history of Royal Bank Of Canada transactions in Lyra Therapeutics, Inc. stock. As of the latest transaction made, Royal Bank Of Canada holds 5,294 shares of LYRA stock, worth $1,058. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5,294
Previous 6,171
14.21%
Holding current value
$1,058
Previous $1,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding LYRA
# of Institutions
54Shares Held
26.2MCall Options Held
21KPut Options Held
0-
Perceptive Advisors LLC New York, NY12.8MShares$2.55 Million0.09% of portfolio
-
Black Rock Inc. New York, NY2.83MShares$565,9950.0% of portfolio
-
Samsara Bio Capital, LLC Palo Alto, CA1.97MShares$393,1370.13% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.79MShares$357,4840.0% of portfolio
-
Ikarian Capital, LLC Dallas, TX1.06MShares$211,6290.04% of portfolio
About Lyra Therapeutics, Inc.
- Ticker LYRA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 31,826,400
- Market Cap $6.37M
- Description
- Lyra Therapeutics, Inc., a clinical-stage therapeutics company, focuses on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases. It's XTreo technology platform is designed to deliver medicines directly to the affected tissue for sustained...